Hypermethylation of rRNA Genes in Alzheimer's Disease
Author Information
Author(s): Pietrzak Maciej, Rempala Grzegorz, Nelson Peter T., Zheng Jing-Juan, Hetman Michal
Primary Institution: University of Louisville
Hypothesis
Is CpG methylation of the rDNA promoter dysregulated across the Alzheimer's disease spectrum?
Conclusion
Hypermethylation of rDNA could serve as a new epigenetic marker for Alzheimer's disease and may contribute to ribosomal deficits.
Supporting Evidence
- Hypermethylation of the rDNA promoter was observed in both MCI and AD groups.
- Genomic rDNA content was elevated in cerebrocortical samples from MCI and AD individuals.
- Significant differences in methylation patterns were found between controls and AD/MCI groups.
Takeaway
In Alzheimer's disease, certain genes that help make ribosomes are turned off too much, which might make it harder for brain cells to work properly.
Methodology
Brain samples from 10 MCI, 23 AD, and 24 control individuals were analyzed for rDNA promoter methylation using bisulfite mapping.
Potential Biases
Potential bias due to the selection of post-mortem samples and the inability to control for all confounding factors.
Limitations
The study is limited to post-mortem brain samples and may not reflect dynamic changes during disease progression.
Participant Demographics
Participants included 10 individuals with mild cognitive impairment (MCI), 23 with Alzheimer's disease (AD), and 24 age-matched controls.
Statistical Information
P-Value
p=0.0002
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website